AllianceBernstein’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $133K | Buy |
49,590
+27,570
| +125% | +$73.9K | ﹤0.01% | 3131 |
|
|
2025
Q1 | $31K | Hold |
22,020
| – | – | ﹤0.01% | 3166 |
|
|
2024
Q4 | $43.8K | Hold |
22,020
| – | – | ﹤0.01% | 3194 |
|
|
2024
Q3 | $69.4K | Hold |
22,020
| – | – | ﹤0.01% | 3165 |
|
|
2024
Q2 | $69.6K | Buy |
+22,020
| New | +$69.6K | ﹤0.01% | 3161 |
|
|
2023
Q1 | – | Sell |
-2,824,956
| Closed | -$10.8M | – | 3175 |
|
|
2022
Q4 | $10.8M | Sell |
2,824,956
-90,204
| -3% | -$346K | ﹤0.01% | 1061 |
|
|
2022
Q3 | $14.1M | Sell |
2,915,160
-46,464
| -2% | -$224K | 0.01% | 940 |
|
|
2022
Q2 | $23.5M | Buy |
2,961,624
+4,568
| +0.2% | +$36.3K | 0.01% | 807 |
|
|
2022
Q1 | $43.4M | Buy |
2,957,056
+149,333
| +5% | +$2.19M | 0.02% | 642 |
|
|
2021
Q4 | $56.7M | Buy |
2,807,723
+153,506
| +6% | +$3.1M | 0.02% | 585 |
|
|
2021
Q3 | $72.1M | Sell |
2,654,217
-399,031
| -13% | -$10.8M | 0.03% | 518 |
|
|
2021
Q2 | $74.3M | Buy |
3,053,248
+422,757
| +16% | +$10.3M | 0.03% | 518 |
|
|
2021
Q1 | $64.2M | Buy |
2,630,491
+829,755
| +46% | +$20.3M | 0.03% | 531 |
|
|
2020
Q4 | $57.6M | Buy |
1,800,736
+502,171
| +39% | +$16.1M | 0.03% | 538 |
|
|
2020
Q3 | $42.8M | Buy |
1,298,565
+370,988
| +40% | +$12.2M | 0.02% | 575 |
|
|
2020
Q2 | $43.4M | Buy |
+927,577
| New | +$43.4M | 0.03% | 551 |
|